Highlights of the San Antonio Breast Cancer Symposium 2019 Part 1: the challenges of tumor heterogeneity

Future Oncol. 2020 Jul;16(21):1497-1502. doi: 10.2217/fon-2020-0309. Epub 2020 May 29.

Authors

John R Benson¹, Dorin Dumitru², Ismail Jatoi³

Affiliations

¹ Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, & School of Medicine, Anglia Ruskin University, Cambridge, UK.
² Breast Unit, Castle Hill Hospital Hull University Teaching Hospitals NHS Trust & Hull York Medical School, Hull, UK.
³ Division of Surgical Oncology, Dale H. Dorn Chair in Surgery, University of Texas Health Science Centre, San Antonio, 78229 TX, USA.

PMID: 32469603
DOI: 10.2217/fon-2020-0309

No abstract available

Keywords: San Antonio; hormone replacement therapy; screening; stromal-epithelial interactions.

Publication types

Congress

MeSH terms

Breast Neoplasms / diagnostic imaging
Breast Neoplasms / epidemiology
Breast Neoplasms / pathology*
Breast Neoplasms / surgery*
Early Detection of Cancer*
Estrogens, Conjugated (USP) / therapeutic use
Female
Humans
Image-Guided Biopsy
Magnetic Resonance Imaging
Mammography
Medroxyprogesterone Acetate / therapeutic use
Neoplasm, Residual
Postmenopause
Radiotherapy
Tumor Microenvironment

Substances

Estrogens, Conjugated (USP)
Medroxyprogesterone Acetate